These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34589111)

  • 1. Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020.
    Ruan L; Li X
    Front Genet; 2021; 12():683542. PubMed ID: 34589111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of nucleic acid aptamers in cancer.
    Pei X; Zhang J; Liu J
    Mol Clin Oncol; 2014 May; 2(3):341-348. PubMed ID: 24772298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Advances in Aptamers for Cancer Diagnosis and Therapy.
    Hori SI; Herrera A; Rossi JJ; Zhou J
    Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29301363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy.
    Han J; Gao L; Wang J; Wang J
    J Cancer; 2020; 11(23):6902-6915. PubMed ID: 33123281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution.
    Kusser W
    J Biotechnol; 2000 Mar; 74(1):27-38. PubMed ID: 10943570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid aptamers against biotoxins: a new paradigm toward the treatment and diagnostic approach.
    Lauridsen LH; Veedu RN
    Nucleic Acid Ther; 2012 Dec; 22(6):371-9. PubMed ID: 23113767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature.
    Nuzzo S; Brancato V; Affinito A; Salvatore M; Cavaliere C; Condorelli G
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid aptamers in diagnosis of colorectal cancer.
    Ahmadyousefi Y; Malih S; Mirzaee Y; Saidijam M
    Biochimie; 2019 Jan; 156():1-11. PubMed ID: 30244135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
    Chen C; Zhou S; Cai Y; Tang F
    NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.
    Giudice V; Mensitieri F; Izzo V; Filippelli A; Selleri C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine.
    Hanžek A; Ducongé F; Siatka C; Duc AE
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer chemistry.
    Röthlisberger P; Hollenstein M
    Adv Drug Deliv Rev; 2018 Sep; 134():3-21. PubMed ID: 29626546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.